We present here a new tool designed to measure the seeverity of neuropsychological and psychiatric symptoms within the so-called ''post-COVID-19 syndrome'' or ''long COVID-19''. Based on the relevant... more
We present here a new tool designed to measure the seeverity of neuropsychological and psychiatric symptoms within the so-called ''post-COVID-19 syndrome'' or ''long COVID-19''. Based on the relevant literature as well as clinical experience of the authors, 13 classes of symptoms have been identified. These became the items of the tool entitled ''Scale of neuropsychological and psychiatry symptoms of the post-COVID-19 syndrome'' (SNP-PC19). This is a five-point Likert-type scale, ranging from 0 (''not at all'') to 4 (''very strongly'') and serving as a measure of the severity of symptoms. The SNP-PC19 was administered online, along with some clinically relevant questions and those aimed at collecting sociodemographics of participants. Fifty-four people answered and the main improvement of the scale was the addition of two items: ''losing patience/temper easily'' and ''frequent and...
We present here a new tool designed to measure the severity of neuropsychological and psychiatric symptoms within the so-called ''post-COVID-19 syndrome'' or ''long COVID-19''. Based on the relevant literature as well as clinical... more
We present here a new tool designed to measure the severity of neuropsychological and psychiatric symptoms within the so-called ''post-COVID-19 syndrome'' or ''long COVID-19''. Based on the relevant literature as well as clinical experience of the authors, 13 classes of symptoms have been identified. These became the items of the tool entitled ''Scale of neuropsychological and psychiatry symptoms of the post-COVID-19 syndrome'' (SNP-PC19). This is a five-point Likert-type scale, ranging from 0 (''not at all'') to 4 (''very strongly'') and serving as a measure of the severity of symptoms. The SNP-PC19 was administered online, along with some clinically relevant questions and those aimed at collecting sociodemographics of participants. Fifty-four people answered and the main improvement of the scale was the addition of two items: ''losing patience/temper easily'' and ''frequent and/or sudden mood swings''. The version of the scale after the pilot study has thus 15 items. It should be highlighted that its psychometric properties have yet to be examined.
Key words: post-COVID-19 syndrome, long COVID-19, pilot study, scale construction, clinical neuropsychology
